Clinicopathological features and prognosis of patients with colorectal Mucinous adenocarcinoma mixed with other pathological components: a nationwide retrospective study in China
Techniques in Coloproctology · 2025
DOI: 10.1007/s10151-025-03225-0 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Techniques in Coloproctology, 2025. Verfasst von J Yuan und 27 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Laparoscopic Technology, Key Laboratory of Metabolism and Gastrointestinal Tumor, Shandong Medicine and Health Key Laboratory of Ge…. Hauptthemen laut MEDLINE: Adenocarcinoma, Mucinous, Colorectal Neoplasms, Neoplasms, Complex and Mixed. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Mucinous adenocarcinoma (MAC) is typically admixed with other pathological components, including conventional adenocarcinoma, signet ring cell carcinoma, and/or neuroendocrine neoplasms. Specifically, signet ring cell differentiation (MASD) is defined as a signet ring cell component comprising less than 50% of the tumor, and neuroendocrine differentiation (MAND) is defined as a neuroendocrine component constituting less than 30%. Furthermore, MAC admixed with conventional adenocarcinoma was defined as classic mucinous adenocarcinoma (CMAC) in this study. Therefore, the study aimed to investigate the clinicopathologic and prognostic differences between patients with CMAC and those with either MASD or MAND [collectively termed mucous adenocarcinoma mixed with other pathological components (MAM)]. METHODS: We collected data from a multi-institutional registry of patients who underwent surgical curative resection for histologically proven MAC between January 2016 and September 2021 at 22 medical institutions in China. Patients with MAC with percentage of signet ring cell ≥ 50% or percentage of neuroendocrine component ≥ 30% were excluded. RESULTS: A total of 2023 patients from 22 medical institutions who met the study criteria were included. MAM, compared to CMAC, showed more aggressive histologic features, including higher rates of lymphovascular invasion (47.0% vs. 18.0%, p < 0.01), perineural invasion (68.0% vs. 35.1%, p < 0.01), T4 stage (33.5% vs. 26.5%, p < 0.01), N2 stage (56.2% vs. 17.8%, p < 0.01), and TNM stage III disease (73.5% vs. 49.2%, p < 0.01). MAMs had lower 3-year overall survival compared to those with CMAC (66.7% vs. 81.6%, p < 0.01). Multivariable analysis indicated that MAMs, including MASD and MAND, was an independent prognostic factor for poor disease-free survival and overall survival. CONCLUSION: Our analysis of a large patient cohort confirmed the aggressive clinicopathological features and poor prognostic outcomes of MAM, including MAND and MASD, compared with CMAC. These findings underscore the need for surveillance protocols for MAM in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Laparoscopic Technology, Key Laboratory of Metabolism and Gastrointestinal Tumor, Shandong Medicine and Health Key Laboratory of General Surgery, Department of General Surgery, The First Affiliated Hos…
- Department of General Surgery, Union Hospital affiliated to Huazhong University of Science and Technology, 430000, Wuhan, Hubei, China.
- Department of General Surgery, Cancer Hospital, Chinese Academy of Medical Sciences, Chaoyang, 100020, Beijing, China.
- Department of General Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Huangpu, 200001, Shanghai, China.
- Department of General Surgery, Yantai Yuhuangding Hospital, Yantai, 264000, Shandong, China.
- Department of General Surgery, Qilu Hospital of Shandong University, Jinan, 250000, Shandong, China.
Zitieren
APA
Yuan, J., He, H., Zhang, P., Guan, X., Yu, M., Zhang, Y., Ning, S., Wang, L., Lv, Y., Jiao, M., Sun, Y., Sun, Q., Ren, X., Liu, D., Zhang, Z., Ye, Z., Li, J., Yu, G., Ma, B., …, & Yang, H. (2025). Clinicopathological features and prognosis of patients with colorectal Mucinous adenocarcinoma mixed with other pathological components: a nationwide retrospective study in China. Techniques in Coloproctology. https://doi.org/10.1007/s10151-025-03225-0
Vancouver
Yuan J, He H, Zhang P, Guan X, Yu M, Zhang Y, et al. Clinicopathological features and prognosis of patients with colorectal Mucinous adenocarcinoma mixed with other pathological components: a nationwide retrospective study in China. Techniques in Coloproctology. 2025. doi:10.1007/s10151-025-03225-0
BibTeX
@article{Yuan2025,
author = {Yuan, J and He, H and Zhang, P and Guan, X and Yu, M and Zhang, Y and Ning, S and Wang, L and Lv, Y and Jiao, M and Sun, Y and Sun, Q and Ren, X and Liu, D and Zhang, Z and Ye, Z and Li, J and Yu, G and Ma, B and Fu, W and Kong, X H and Jing, C and Tao, K and Sun, Y and Jiang, C and Chen, J and Zhang, G and Yang, H},
title = {Clinicopathological features and prognosis of patients with colorectal Mucinous adenocarcinoma mixed with other pathological components: a nationwide retrospective study in China},
journal = {Techniques in Coloproctology},
year = {2025},
doi = {10.1007/s10151-025-03225-0}
}
EUVIMED